Award of phase 1 clinical trial unit for therapeutics against infectious diseases, IDIQ contract. Period of performance: december 15, 2014 through december 14, 2021.
Ended Awarded Last action
- Contract number
- HHSN272201500005I
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755 Part of General Dynamics Corp
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 13 $15,831,279 obligated
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Phase i clinical trial unit for therapeutics against infectious diseases Award Notice · Posted Oct 31, 2013
- Phase i clinical trial unit for therapeutics against infectious diseases Award Notice · Posted Sep 19, 2013
- Combined order value
- $15,831,279 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 18% used
- $90,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
Award details come from SAM.gov/FPDS.
Task orders
Show all 13
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 13
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Iqvia Government Solutions Inc. | $181,898 | |
| Iqvia Government Solutions Inc. | $280,268 |
Quick answers
Who was awarded contract HHSN272201500005I?
HHSN272201500005I was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 15, 2014.
How much is contract HHSN272201500005I worth?
Orders under HHSN272201500005I have obligated $15,831,279. HHSN272201500005I's own ceiling is $90,000,000.
How many orders have been placed under contract HHSN272201500005I?
13 orders have been placed under HHSN272201500005I, the latest on December 15, 2021.
Who can order from contract HHSN272201500005I?
HHSN272201500005I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN272201500005I part of a contract vehicle?
Yes. HHSN272201500005I is part of Therapeutics Against Infectious Diseases Phase 1.
Was contract HHSN272201500005I competed?
The extent of competition for HHSN272201500005I was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV